Purpose: Osteoarthritis is more prevalent in women than men. Joint replacement is an effective treatment option for end-stage knee OA and its utilization is increasing rapidly. There are, however, limited data on gender differences in surgical outcomes after total joint arthroplasty. We sought to examine gender differences in overall mortality, major complications, revision rates and re-admission rates after primary total knee arthroplasty.. Methods: The sample consisted of all primary knee total joint arthroplasties performed in the State of Pennsylvania during the fiscal year 2002. Primary knee arthroplasty was identified using the International Classification of Diseases, Ninth revision, Clinical Modification (ICD-9-CM) code 81.54 in the Pennsylvania Health Care Cost Containment Council (PHC4) Database. We excluded patients with revision knee arthroplasty or with hip joint related procedures during index hospitalization. PHC4 includes demographic data from all patient discharges from 170 non-governmental (i.e. non-Veterans Administration) acute care hospitals in the State of Pennsylvania. We used ICD-9 codes to identify major complications such as venous thromboembolism (VTE), myocardial infarction (MI), prosthetic device malfunction, surgical wound infection and revision knee arthroplasty (ICD-9 codes, 81.55, 0080, 0081, 0082, 0083, and 0084). We examined the associations between gender and allcause mortality, major surgical complications. risk of surgical revision at 1-year and at 5-years after index arthroplasty. We adjusted for age, race or ethnicity, hospital teaching status (teaching or non-teaching), insurance status (none or unknown, Medicaid, Medicare/ government, or private), hospital procedure volume (0-100 and >100), and length of hospital stay and the 3M[[Unsupported Character -]] All Patient Refined-Diagnosis Related Group Risk of Mortality (APR-ROM) score, a validated surgical risk score. Results: In sample consisting of 19,312 primary total knee arthroplasties, there were 47 deaths (0.2%) at 30 days and 232 (1.2%) at one year. Within 30 days of index TKA, 1076 (5.8%) had major complications. Table 1 shows unadjusted rates of major complications. Compared to women, men had higher adjusted odds of one-year mortality (Odds Ratio (OR), 1.50; 95% CI, [1.22-1.86]), wound infections (1.23 [1.01-1.49]) and 30-day readmission (1.44 [0.80-2.57]) after primary TKA. Men also had significantly higher risk of revision arthroplasty of the primary TKA at 1-year (Hazard Ratio(HR), 1.60; 95% CI¼ 1.27-2.03) and 5-years (1.21; 95% CI¼ 1.08-1.37). There were no statistically significant gender differences in the rates of short-term complications (i.e., venous thromboembolism, myocardial infarction, prosthetic device malfunction or 30-day mortality). Conclusion: In a large regional sample of patients who underwent primary total knee arthroplasty, men had higher rates of adverse surgical outcomes including higher short-and intermediate-term revision rates compared to women.
EFFECTIVENESS OF HYALURONIC ACID INTRA-ARTICULAR INJECTION FOR PATIENTS WITH KNEE OSTEOARTHRITIS
Y. Kusayama, Y. Akamatsu, K. Kumagai, Y. Fujiwara, T. Saitou. Yokohama City Univ., Sch. of Med., Kanagawa prefecture Yokohama city, Japan Purpose: Hyaluronic acid (HA) intra-articular injection for the treatment of patients with knee osteoarthritis (OA) was firstly manufactured in 1987, and has been routinely used in Japan. However, there was only a small amount of evidence. We have performed five weekly HA injections according to the insurance policy. The purpose of this study was to investigate the change of the nature of synovial fluid (SF) and clinical symptoms before and after five weekly HA injections. Method: Fifteen patients (17 knees) with symptomatic knee OA were enrolled between January 2010 and July 2011. We conducted 5 weekly intra-articular injections (Artz, Seikagaku Corporation, Tokyo, Japan) after drainage of SF in every cases. The arthrocentesis was performed through lateral mid patellar portal using a 21-gauge needle and syringe, while avoiding the contamination of blood. We checked total volume of SF drainage before each HA injection. Also, we measured molecular weight of hyaluronic acid (HA),chondroitin 4-sulfate (C4S), chondroitin 6-sulfate (C6S) and keratan sulfate (KS) before first and fifth time. We excluded the case if the SF could not be extracted. We decided not to administer aspirin and nonsteroidal anti-inflammatory drugs six weeks before injections and during injections. The range of motions (ROM) were measured and clinical symptoms were using American Knee Society (AKS) knee and function scores. All knees were classified using the Kellgren-Lawrence grades (KL grade), and the femorotibial angle (FTA) was measured on the radiogram. Result: Four dry knees were excluded before the first injection. Thirteen knees (right 8 and left 5 knees) were examined. Mean age was 63 AE 10.7 years old, and mean body mass index was 22.1 AE 2.5 kg/m 2 . KL grades were grade 2 in 9 knees and grades 3-4 in 4 knees. Mean FTA was 178.5 AE 3.5 . We didn't have complications and side effects. Mean volume of SF, which was 11.8ml before first injection, and 6.2 m before fifth injection, significantly decreased after HA injections (p < 0.05). Mean AKS knee score, which was 61 points before first injection and 77 points before fifth injection, significantly improved after HA injections (p < 0.0001). Mean ROM, which was 134 AE 10 before first injection and 140.8 AE 7 before fifth injection, significantly improved after HA injections (p < 0.009). Mean molecular weight of HA, C4S, C6S and KS, which were 1.4 mg/ml, 15.1 nmol/m 50.7 nmol/ml and 4.3 micro g/ml, respectively, before first injection, changed to 1.7 mg/ml, 12.7 nmol/ml, 41.9 nmol/ml and 3.7 micro g/ml, respectively, before fifth injection. 
